Department of Hematology, AIIMS, New Delhi, India.
Department of Laboratory Sciences and Molecular Medicine, Army Hospital (R and R), Delhi Cantt, New Delhi, India.
Indian J Pathol Microbiol. 2021 Oct-Dec;64(4):741-745. doi: 10.4103/IJPM.IJPM_1317_20.
The spectrum of thrombophilia in women with recurrent pregnancy loss (RPL) is different in Indian ethnicity as reported by few studies. We aimed to study the prevalence of thrombophilia in RPL patients referred to hematology department of a tertiary centre.
This is an observational study of 112 RPL patients with no apparent cause after extensive workup for non-hematological causes. The investigations performed were routine coagulogram, APLA workup, plasma homocysteine, MTHFRC677T polymorphisms, Protein C, free Protein S, Anti-thrombin III levels, test for Activated Protein C resistance (APC-R) ,Factor V Leiden and Prothrombin gene G20210A mutation.
Of 112 patients, at least one thrombophilia was identified in 70.5% and combined thrombophilia in 12.5% patients. Hyperhomocysteinemia (30.4%) and APLA (25.9%) were the commonest thrombophilia whereas anticoagulant defects were seen in 12.5% of the population. Protein C deficiency (5.35%) was the commonest anticoagulant defect followed by APCR (3.6%). Mutational analysis revealed MTHFRC677T polymorphism in 20.5% whereas Factor V Leiden heterozygous in 1.8% patients. None of the patients had homozygous Factor V Leiden or Prothrombin gene G20210A mutation. Hyperhomocysteinemia, MTHFRC677T and Protein C deficiency were more associated with early pregnancy losses whereas Protein S deficiency, Factor V Leiden and APLA caused both early and late losses. Patients with greater number of losses were positive for homozygous MTHFRC677T, factor V Leiden and APLA.
The approach to investigating Indian women with RPL should be based on the prevalence of thrombophilia which is unique to Indian ethnicity.
几项研究报告称,在印度人群中,复发性妊娠丢失(RPL)患者的血栓形成倾向谱与其他人群不同。我们旨在研究在一家三级中心血液科就诊的 RPL 患者中血栓形成倾向的患病率。
这是一项对 112 例经过广泛非血液学原因检查后仍无明显原因的 RPL 患者的观察性研究。进行的检查包括常规凝血谱、APLA 检查、血浆同型半胱氨酸、MTHFRC677T 多态性、蛋白 C、游离蛋白 S、抗凝血酶 III 水平、激活蛋白 C 抵抗(APC-R)检测、因子 V Leiden 和凝血酶原基因 G20210A 突变。
在 112 例患者中,70.5%至少存在一种血栓形成倾向,12.5%存在联合血栓形成倾向。高同型半胱氨酸血症(30.4%)和 APLA(25.9%)是最常见的血栓形成倾向,而抗凝缺陷在 12.5%的人群中可见。蛋白 C 缺乏症(5.35%)是最常见的抗凝缺陷,其次是 APC-R(3.6%)。突变分析显示 MTHFRC677T 多态性占 20.5%,杂合子因子 V Leiden 占 1.8%。没有患者存在纯合子因子 V Leiden 或凝血酶原基因 G20210A 突变。高同型半胱氨酸血症、MTHFRC677T 和蛋白 C 缺乏症与早期妊娠丢失更为相关,而蛋白 S 缺乏症、因子 V Leiden 和 APLA 可导致早期和晚期妊娠丢失。具有更多流产史的患者存在纯合子 MTHFRC677T、因子 V Leiden 和 APLA 阳性。
对印度 RPL 患者的检查方法应基于血栓形成倾向的患病率,而血栓形成倾向的患病率在印度人群中是独特的。